• Mashup Score: 0

    In contrast to previous coronaviruses, SARS-CoV-2, the virus causing COVID-19, produces many CV consequences, according to a presentation at the Heart in Diabetes CME Conference. “In the COVID-19 era, the spectrum of cardiovascular presentations ranged from acute coronary syndrome to heart failure to cardiogenic shock, most of which [had] a characterization of myocarditis-like presentation

    Tweet Tweets with this article
    • ICYMI: Early reports showed evidence of myocardial injury in 25% to 30% of patients hospitalized for COVID-19, most commonly in patients with preexisting CVD #HID2020 @yhandelsmanmd @heartindiabetes @BiykemB #CardioTwitter @EndocrineToday @HealioPulm https://t.co/WQGzkgTa9f

  • Mashup Score: 4

    In contrast to previous coronaviruses, SARS-CoV-2, the virus causing COVID-19, produces many CV consequences, according to a presentation at the Heart in Diabetes CME Conference. “In the COVID-19 era, the spectrum of cardiovascular presentations ranged from acute coronary syndrome to heart failure to cardiogenic shock, most of which [had] a characterization of myocarditis-like presentation

    Tweet Tweets with this article
    • ICYMI: Early reports showed evidence of myocardial injury in 25% to 30% of patients hospitalized for COVID-19, most commonly in patients with preexisting CVD #HID2020 @yhandelsmanmd @heartindiabetes @BiykemB #CardioTwitter @EndocrineToday @HealioPulm https://t.co/WQGzkgTa9f

  • Mashup Score: 4

    In contrast to previous coronaviruses, SARS-CoV-2, the virus causing COVID-19, produces many CV consequences, according to a presentation at the Heart in Diabetes CME Conference. “In the COVID-19 era, the spectrum of cardiovascular presentations ranged from acute coronary syndrome to heart failure to cardiogenic shock, most of which [had] a characterization of myocarditis-like presentation

    Tweet Tweets with this article
    • In contrast to previous coronaviruses, SARS-CoV-2, the virus causing COVID-19, produces many CV consequences, according to a presentation at #HID2020 @yhandelsmanmd @heartindiabetes @BiykemB #CardioTwitter @EndocrineToday @InfectDisNews @HealioPulm https://t.co/WQGzkgTa9f

  • Mashup Score: 0

    Continuous glucose monitoring not only leads to better glycemic management for people with diabetes, but could also lead to cost savings, according to a speaker at Heart in Diabetes. “CGM is now considered by most experts a standard of care for managing patients with type 1 diabetes,” George Grunberger, MD, FACP, MACE, chairman of the Grunberger Diabetes Institute, clinical professor

    Tweet Tweets with this article
    • ICYMI: #CGM provides cost savings in addition to health benefits in people with #diabetes @heartindiabetes #HID2020 @GrunbergerDI https://t.co/ghGHxH5OrI

  • Mashup Score: 2

    Continuous glucose monitoring not only leads to better glycemic management for people with diabetes, but could also lead to cost savings, according to a speaker at Heart in Diabetes. “CGM is now considered by most experts a standard of care for managing patients with type 1 diabetes,” George Grunberger, MD, FACP, MACE, chairman of the Grunberger Diabetes Institute, clinical professor

    Tweet Tweets with this article
    • ICYMI: “Now we have enough data to show #CGM is cost-effective in terms of long-term glycemic improvement, and also for the acute emergencies resulting in emergency department or in-patient admissions.” #diabetes @heartindiabetes #HID2020 @GrunbergerDI https://t.co/ghGHxH5OrI

  • Mashup Score: 0

    Continuous glucose monitoring not only leads to better glycemic management for people with diabetes, but could also lead to cost savings, according to a speaker at Heart in Diabetes. “CGM is now considered by most experts a standard of care for managing patients with type 1 diabetes,” George Grunberger, MD, FACP, MACE, chairman of the Grunberger Diabetes Institute, clinical professor

    Tweet Tweets with this article
    • CGM use provides both health benefits and cost savings to people with #diabetes @heartindiabetes #HID2020 @GrunbergerDI https://t.co/2PgZZXfUID

    • CGM use provides both health benefits and cost savings to people with #diabetes @heartindiabetes #HID2020 @GrunbergerDI https://t.co/z48uqGogTA

  • Mashup Score: 0

    Cardiologists and clinicians do not often recognize the sex-specific CVD pathophysiology in women, especially when using imaging modalities to diagnose patients, according to a speaker.Coronary CTA may provide a benefit in women compared with functional imaging for diagnosis and for treatment planning, Matthew J. Budoff, MD, FACC, professor of medicine in the division of cardiology at Harbor-UCLA

    Tweet Tweets with this article
    • ICYMI: Coronary CTA may provide a benefit in women compared with functional imaging for diagnosis and for treatment planning, @heartindiabetes #HID2020 #cardiotwitter @BudoffMd https://t.co/8WkbOgW2Xp